---
schema_version: "secwatch.filing_event.v1"
accession: "0000200406-23-000112"
form_type: "8-K"
ticker: "JNJ"
cik: "0000200406"
company_name: "JOHNSON & JOHNSON"
filed_at: "2023-12-05T23:59:59+00:00"
generated_at: "2026-06-07T18:19:38.745657+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# JNJ holds investor meeting at NYSE to present strategy, pipeline, and long-term outlook

## Summary
- December 5, 2023: JNJ host Enterprise Business Review at NYSE for the investment community.
- Presented overarching strategy, Innovative Medicine and MedTech pipelines, and long-term financial outlook.
- Press release and webcast materials available at https://jnjbusinessreview.q4ir.com/.
- No specific financial guidance, numbers, or changes disclosed in the filing.

## SEC filing metadata
- accession: 0000200406-23-000112
- form_type: 8-K
- ticker: JNJ
- cik: 0000200406
- company_name: JOHNSON & JOHNSON
- filed_at: 2023-12-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/200406/000020040623000112/0000200406-23-000112-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/200406/000020040623000112/jnj-20231205.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000200406-23-000112
- JSON: https://secwatch.observer/filing/0000200406-23-000112.json
- Plain text: https://secwatch.observer/filing/0000200406-23-000112.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.